Declotting Devices Market Report 2026

Declotting Devices Market Overview

• Declotting Devices market size has reached to $2.26 billion in 2025 • Expected to grow to $3.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.6% • Growth Driver: Growth of Declotting Devices Market Amid Rising Heart Attack and Stroke Cases • Market Trend: Innovation In Declotting Devices Enhanced Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Declotting Devices Market?

Declotting devices refer to medical instruments designed to remove clots (thrombi) from blood vessels in emergencies where clotting obstructs normal blood flow. These devices are used in conditions such as deep vein thrombosis (DVT), where clots may lead to serious complications like pulmonary embolism. The main products in declotting devices are mechanical declotting devices and embolectomy balloons. A mechanical declotting device is a medical tool designed to remove blood clots from blood vessels through mechanical means, and it is primarily used to restore normal blood flow and prevent complications in conditions such as deep vein thrombosis or pulmonary embolism. The declotting devices include thrombectomy devices such as aspiration thrombectomy devices, percutaneous mechanical thrombectomy devices, and others, and are utilized in various end-use settings, including hospitals, clinics, and others.

What Is The Declotting Devices Market Growth Forecast?

The declotting devices market size is expected to see strong growth in the next few years. It will grow to $3.1 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing prevalence of cardiovascular and thrombotic disorders, growing demand for rapid emergency interventions, rising adoption of minimally invasive vascular procedures, expansion of interventional radiology and cardiology centers, improving access to advanced thrombectomy devices. Major trends in the forecast period include rising adoption of minimally invasive declotting procedures, growing use of mechanical thrombectomy over pharmacological methods, increasing preference for rapid clot removal in emergency care, expansion of declotting procedures in acute vascular conditions, growing demand for precision and safety in thrombus removal.

Global Declotting Devices Market Segmentation

1) By Product: Mechanical Declotting Device, Embolectomy Balloon 2) By Thrombectomy Device: Aspiration Thrombectomy Devices, Percutaneous Mechanical Thrombectomy Devices, Other Thrombectomy Devices 3) By End Use: Hospitals, Clinics, Other End Uses Subsegments: 1) By Mechanical Declotting Device: Thrombectomy Devices, Rotational Thrombectomy Devices, Aspiration Catheters, Stent Retriever Devices, Rotational And Suction-Based Thrombectomy Devices 2) By Embolectomy Balloon: Single-Lumen Embolectomy Balloon, Dual-Lumen Embolectomy Balloon, High-Pressure Embolectomy Balloons, Low-Pressure Embolectomy Balloons

What Is The Driver Of The Declotting Devices Market?

The increasing incidence of vascular disorders is expected to propel the growth of the declotting devices market going forward. Vascular disorders are medical conditions that affect the blood vessels, including the arteries, veins, and capillaries, disrupting normal blood flow and potentially leading to various health complications. The incidence of vascular disorders is on the rise, primarily due to the increasing prevalence of risk factors such as obesity, sedentary lifestyles, and aging populations. Declotting devices are used in vascular disorders to rapidly and effectively remove or dissolve blood clots, restoring normal blood flow and preventing complications. For instance, in January 2025, according to the The National Institutes of Health (NIH), US-based, Department of Health and Human Services, the worldwide cost of stroke surpasses US$890 billion each year, accounting for about 0.66% of global GDP, and is anticipated to almost double by 2050. Therefore, the increasing incidence of vascular disorders is driving the growth of the declotting devices industry.

Key Players In The Global Declotting Devices Market

Major companies operating in the declotting devices market are Medtronic plc, Stryker Corporation, Penumbra Inc, Boston Scientific Corporation, Terumo Corporation, Abbott Laboratories, Teleflex Incorporated, Argon Medical Devices Inc, B Braun Melsungen, Phenox GmbH, Acandis GmbH & Co KG, Rapid Medical Inc, AngioDynamics Inc, Imperative Care Inc, Balt Extrusion SAS, Vesalio LLC, Merit Medical Systems Inc, Natec Medical Ltd, Control Medical Technology LLC, Sino Medical Sciences Technology Inc

Global Declotting Devices Market Trends and Insights

Major companies operating in the declotting devices market are focused on developing advanced products such as computer-aided declotting devices (thrombectomy) to enhance precision and efficacy in clot removal procedures. Computer-aided declotting devices, also known as thrombectomy devices, are advanced medical instruments designed to assist in the removal of blood clots from blood vessels. For instance, in June 2023, Penumbra Inc., a US-based medical device manufacturing company, launched Lightning Bolt 7, an advanced and robust arterial declotting (thrombectomy) system. Lightning Bolt 7 introduces a new approach to clot removal called modulated aspiration, integrating Penumbra's Lightning Intelligent Aspiration technology with an advanced microprocessor algorithm. Lightning Bolt 7 is designed to rapidly extract large, fibrous arterial blood clots with minimal blood loss, effectively treating acute limb ischemia (ALI), hibernating thrombus, and visceral occlusions. This represents a significant advancement in declotting devices by offering a more efficient and precise tool for physicians conducting thrombectomy procedures.

What Are Latest Mergers And Acquisitions In The Declotting Devices Market?

In April 2023, Abbott Laboratories, a US-based medical device company, acquired Cardiovascular Systems, Inc. for an undisclosed amount. With this acquisition, Abbott Laboratories aims to expand its vascular health portfolio by adding advanced atherectomy solutions for treating arterial disease. This strengthens Abbott's minimally invasive treatment options for peripheral and coronary artery diseases. Cardiovascular Systems, Inc. is a US-based manufacturer of medical devices primarily focused on treating peripheral and coronary artery disease.

Regional Outlook

North America was the largest region in the declotting devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Declotting Devices Market?

The declotting devices market consists of sales of ultrasound-assisted thrombolysis devices, hemolytic embolectomy devices, and rotational embolectomy devices. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.